These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 25458789)

  • 1. Colon cancer: cancer stem cells markers, drug resistance and treatment.
    Kozovska Z; Gabrisova V; Kucerova L
    Biomed Pharmacother; 2014 Oct; 68(8):911-6. PubMed ID: 25458789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.
    Xie ZY; Lv K; Xiong Y; Guo WH
    Oncol Res Treat; 2014; 37(11):666-8, 670-2. PubMed ID: 25427584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
    Su P; Yang Y; Wang G; Chen X; Ju Y
    Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.
    Mohammad IS; He W; Yin L
    Biomed Pharmacother; 2018 Apr; 100():335-348. PubMed ID: 29453043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of chemoresistant CD133+ cancer stem cells from human glioblastoma cell line U138MG using multiple assays.
    Warrier S; Pavanram P; Raina D; Arvind M
    Cell Biol Int; 2012; 36(12):1137-43. PubMed ID: 22770475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
    To KK; Poon DC; Wei Y; Wang F; Lin G; Fu LW
    Biochem Pharmacol; 2015 Sep; 97(1):27-37. PubMed ID: 26206183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting the ABCs of multidrug resistance in cancer chemotherapy.
    Tiwari AK; Sodani K; Dai CL; Ashby CR; Chen ZS
    Curr Pharm Biotechnol; 2011 Apr; 12(4):570-94. PubMed ID: 21118094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
    Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
    Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells.
    McIntosh K; Balch C; Tiwari AK
    Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):633-44. PubMed ID: 27116192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversing agents for ATP-binding cassette drug transporters.
    Lee CH
    Methods Mol Biol; 2010; 596():325-40. PubMed ID: 19949930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvianolic acid B reverses multidrug resistance in nude mice bearing human colon cancer stem cells.
    Guo P; Wang J; Gao W; Liu X; Wu S; Wan B; Xu L; Li Y
    Mol Med Rep; 2018 Aug; 18(2):1323-1334. PubMed ID: 29845279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
    Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
    Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4-mediated drug resistance in colon cancer stem cells.
    Todaro M; Perez Alea M; Scopelliti A; Medema JP; Stassi G
    Cell Cycle; 2008 Feb; 7(3):309-13. PubMed ID: 18235245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance].
    Wei N; Sun H; Liu GT
    Yao Xue Xue Bao; 2010 Oct; 45(10):1205-11. PubMed ID: 21348297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid.
    Bizzarro V; Belvedere R; Milone MR; Pucci B; Lombardi R; Bruzzese F; Popolo A; Parente L; Budillon A; Petrella A
    Oncotarget; 2015 Sep; 6(28):25076-92. PubMed ID: 26312765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ABCs of cancer stem cell drug resistance.
    Elliott A; Adams J; Al-Hajj M
    IDrugs; 2010 Sep; 13(9):632-5. PubMed ID: 20799146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.